demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
ivermectin plus doxycycline NCT04523831 ...

1 studies excluded by filtering options 0

7995 Hazan, 2021 2320excludednot a RCTrisk of bias not avaialble